Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ARCTURUS THERAPEUTICS HOLDINGS INC.

(ARCT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Arcturus Therapeutics : to Partner With Vingroup to Launch its COVID-19 Vaccine Candidate Manufacturing Facility in Vietnam

08/02/2021 | 09:01am EST


© MT Newswires 2021
All news about ARCTURUS THERAPEUTICS HOLDINGS INC.
11/22Arcturus Therapeutics to Participate in Piper Sandler 33rd Annual Healthcare Conference
BU
11/18Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BU
11/16ARCTURUS THERAPEUTICS HOLDINGS INC. : Other Events, Financial Statements and Exhibits (for..
AQ
11/16Cantor Fitzgerald Adjusts Price Target on Arcturus Therapeutics Holdings to $93 From $8..
MT
11/09Barclays Adjusts Price Target on Arcturus Therapeutics to $31 From $46, Keeps Underweig..
MT
11/09ARCTURUS THERAPEUTICS HOLDINGS INC. Management's Discussion and Analysis of Financial ..
AQ
11/08Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progre..
PU
11/08ARCTURUS THERAPEUTICS : Q3 Earnings Snapshot
AQ
11/08Arcturus Therapeutics Q3 Loss Widens -- Stock Down 1% After-Hours
MT
11/08Arcturus Therapeutics Holdings Inc. Reports Earnings Results for the Third Quarter Ende..
CI
More news
Analyst Recommendations on ARCTURUS THERAPEUTICS HOLDINGS INC.
More recommendations
Financials (USD)
Sales 2021 24,0 M - -
Net income 2021 -206 M - -
Net cash 2021 306 M - -
P/E ratio 2021 -4,45x
Yield 2021 -
Capitalization 912 M 912 M -
EV / Sales 2021 25,2x
EV / Sales 2022 2,48x
Nbr of Employees 118
Free-Float 86,0%
Chart ARCTURUS THERAPEUTICS HOLDINGS INC.
Duration : Period :
Arcturus Therapeutics Holdings Inc. Technical Analysis Chart | ARCT | US03969T1097 | MarketScreener
Technical analysis trends ARCTURUS THERAPEUTICS HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 34,60 $
Average target price 85,45 $
Spread / Average Target 147%
EPS Revisions
Managers and Directors
Joseph E. Payne President, Chief Executive Officer & Director
Andrew H. Sassine Chief Financial Officer & Director
Peter C. Farrell Chairman
Padmanabh Chivukula Secretary, Chief Operating & Scientific Officer
Steven G. Hughes Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
ARCTURUS THERAPEUTICS HOLDINGS INC.-20.24%912
MODERNA, INC.153.98%107 578
LONZA GROUP AG25.98%56 683
IQVIA HOLDINGS INC.46.84%50 262
SEAGEN INC.-16.63%26 699
CELLTRION, INC.-42.48%23 888